Status:
COMPLETED
Opioid Reduction Program for Total Knee Replacement Patients
Lead Sponsor:
University of Tennessee
Collaborating Sponsors:
Campbell Clinic
Conditions:
Knee Injuries
Knee Injuries and Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the context of prescribed opioids, research suggests that increased exposure is associated with long-term opioid use. Orthopedic surgeries are associated with the prescribing of more opioid narcoti...
Detailed Description
The purpose of the study is to build upon our existing research to: (1) explore the efficacy of a disseminable Opioid Reduction Program (ORP) to reduce long-term use of prescribed opioids following TK...
Eligibility Criteria
Inclusion
- 18 years or older.
- Presenting for a total knee replacement (TKR) surgery at Campbell Clinic which will result in an opioid prescription.
- Access to a telephone.
- Able to consent in English.
Exclusion
- Under the age of 18.
- Contraindications to use of opioid medication.
- No access to a telephone.
- Unable to understand consent materials in English.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT05414942
Start Date
August 1 2021
End Date
May 25 2022
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tennessee Health Science Center
Memphis, Tennessee, United States, 38163